These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21304000)

  • 1. Markers of pancreatic cancer: working toward early detection.
    Goggins M
    Clin Cancer Res; 2011 Feb; 17(4):635-7. PubMed ID: 21304000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pancreatic cancer research: moving towards early detection.
    He XY; Yuan YZ
    World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
    Babic A; Wolpin BM
    Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein-metabolite panel for early-stage pancreatic cancer.
    Burki TK
    Lancet Oncol; 2018 Oct; 19(10):e512. PubMed ID: 30146244
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
    Caputo D; Caracciolo G
    Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine test can detect early stage pancreatic cancer.
    Bagcchi S
    Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic cancer: current understanding of molecular and genetic aetiologies.
    Gall TM; Wasan H; Jiao LR
    Postgrad Med J; 2015 Oct; 91(1080):594-600. PubMed ID: 26124188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
    Crawford HC; Wallace MB; Storz P
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for Pancreatic Cancer.
    Wada K; Takaori K; Traverso LW
    Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers in pancreatic ductal adenocarcinomas.
    Hezel AF; Bardeesy N
    Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
    Chari ST; Sharma A; Maitra A
    Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic cancer and cancer screening programs: from nihilism to hope.
    Pezzilli R; Corinaldesi R; Morselli-Labate AM
    JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
    Comandatore A; Balsano R; Immordino B; Arguedas D; Capula M; Baglio SR; Garajovà I; Malapelle U; Morelli L; Giovannetti E
    Crit Rev Oncol Hematol; 2022 May; 173():103659. PubMed ID: 35398264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
    Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.